Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? When using generators, many people overlook or are confused by bonding and grounding.

Critical React Server Components flaw enables remote code execution, prompting urgent crypto industry warnings as attackers exploit CVE-2025-55182 to drain wallets and deploy malware across vulnerable ...

Georgia's 408 public libraries delivered an estimated $1.06 billion in services and economic benefits during fiscal year 2024, generating $3.75 in value for every dollar of public funding, according ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

A critical vulnerability in the popular expr-eval JavaScript library, with over 800,000 weekly downloads on NPM, can be exploited to execute code remotely through maliciously crafted input. The ...

Generate Capital PBC, an investment firm that has raised more than $14 billion since 2014 to bankroll largely US-based sustainable projects, has cut staff as the withdrawal of US policy support upends ...